Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Poppi is a fast-growing U.S. functional soda brand that markets itself as "prebiotic soda," containing apple cider vinegar and prebiotic fiber from agave inulin and cassava root fiber. It claims to support gut health but has faced scrutiny over the substantiation of its health claims. The company was acquired by PepsiCo in May 2025 for $1.95 billion after rapid growth and strong sales performance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Poppi.